Emerging Risk Of Inappropriate Medication Utilization In Geriatric Oncology Patients And Various Approaches For Improving Appropriateness Of Medication Use

Geratric oncology patients are subject to a high risk of medication: comorbidity care, cancer treatment, treatment of help and self-medication. Cytotoxic drugs that are used in cancer chemotherapy are well known for their wide range of toxicities due to their narrow therapeutic index. Polypharmacy occured as a result of complexity of medications and emerging medication pill counts, all of which can lead to failure approaches for the preventing of cancer, for example, diagnosis delays and the end of precocious medication as a consequence of toxicity or events of adverse drugs. This includes all potentially harmful pharmaceutical items, (PIMs, for example drugs or the combination of medicine with an undesirable risk / benefit ratio), as well as possible prescription omissions. Researchers have invent and modifies many criterias or tools inorder analyse and screen the occurrence of several improper drug prescribing and use in elderly patients and identifies PIMs and PPOs. For alerting the physician on inappropriate prescribing in elderly patients explicit criterias are widely and acceptably used as it simplify the optimization of medication. To improving the appropriateness of medication and ADR minimization is the primary goal on inappropriate medication inventory tool .Currently Beer’s criteria lacks enough evidence or relevance for supporting as a better intervention tool. The STOPP / START and FORTA list based on the highly significant patient-related results in the latest RCT are actually satisfied to identify the relevant inappropriate medications.